![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/517 | (2006.01) |
A61K 31/517 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61K 31/395 | (2006.01) | ||
C12Q 1/6886 | (2013.01) | ||
A61K 31/436 | (2006.01) | ||
C12Q2600/156 | (2013.01) | ||
A61K 31/7088 | (2006.01) | ||
C12Q2600/106 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 3773551 |
(13) | Kind of document | T |
(96) | European patent application number | 19775368.4 |
Date of filing the European patent application | 2019-03-27 | |
(97) | Date of publication of the European application | 2021-02-17 |
(45) | Date of publication and mention of the grant of the patent | 2024-10-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2019/024353 |
Date | 2019-03-27 |
(87) | Number | WO 2019/191279 |
Date | 2019-10-03 |
(30) | Number | Date | Country code |
201862648629 P | 2018-03-27 | US | |
201862688049 P | 2018-06-21 | US |
(72) |
ROBICHAUX, Jacqulyne , US
HEYMACH, John, V. , US
|
(73) |
Board of Regents, The University of Texas System ,
210 West 7th St., Austin, TX 78701,
US
|
(54) | COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING HER2 EXON 19 MUTATIONS |
COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING HER2 EXON 19 MUTATIONS |